{
  "trial_id": "NCT00422292",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Healthy",
      "label": "met",
      "evidence": "medical history and physical examination"
    },
    {
      "criterion": "Aged 9 months (249 to 291 days) for Groups 1, 2, and 3 or aged 12 months (365 to 386 days) for Group 4 at the time of enrollment",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "The parent or legal guardian has signed and dated the Institutional Review Board (IRB)-approved informed consent form.",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "History of documented invasive meningococcal disease or previous meningococcal vaccination",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Known human immunodeficiency virus (HIV), hepatitis B, or hepatitis C seropositivity as reported by the parent or legal guardian",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "The patient has been previously vaccinated with meningococcal group ACWY conjugate vaccine and meningococcal group B vaccine. The genetic survey revealed ADAMTS13 >10%. He was treated with plasma exchange and corticosteroids.",
  "_meta": {
    "topic_id": "68",
    "trial_id": "NCT00422292",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}